CIR and F2i: Bahrain sovereign wealth fund invests in KOS

The deal, concluded through F2i Healthcare, confirms international investor interest for the healthcare company

Milan, August 1 2016 – CIR-Compagnie Industriali Riunite S.p.A. and F2i hereby announce that Bahrain Mumtalakat Holding Company (“Mumtalakat”), the sovereign wealth fund of the Kingdom of Bahrain, has invested in KOS, a leading Italian company in the healthcare sector.

Mumtalakat’s investment was made indirectly through the purchase of an interest in F2i Healthcare, the vehicle company controlled by the F2i Second Fund in which other investors have interests, which has been a shareholder of KOS since May of this year. As part of the deal, CIR sold to F2i Healthcare 3.2% of KOS for an amount of approximately € 20 million.

Following this transaction, the shareholding structure of KOS consists of CIR with 59.53% and F2i Healthcare with 40.47%. F2i remains the controlling shareholder of F2i Healthcare, with a stake of 61.4%. The entry of Mumtalakat into the capital of F2i Healthcare confirms international investor interest for KOS. This is the first investment made by Mumtalakat in Italy.

KOS is the number four private Italian operator in the healthcare sector in terms of revenues. With 76 facilities in Italy, businesses in India and the United Kingdom and some 5,200 employees, the KOS group closed 2015 with sales revenues of approximately € 430 million and net income of approximately € 20 million.

Download pdf